NCT06634420 Phase 3 Active not recruiting
HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE) Study sponsor: Intellia Therapeutics
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Changes Study details Primary completion 2026-02-10 Actual
Enrollment · participants 80 Actual
Source updated 2026-07-29 Last update listed in the registry record
Version history
Changes to this trial Last 12 months
Posted 2026-05-15 · 4 fields changed
Participant count type changed
Enrollment · participant count changed
− Before 60 participants (planned)
+ After 80 participants (actual)
Completion date type changed
Primary completion date changed
Check registry source
This database covers selected trials and recorded edits. Some past edits may be missing, and saved text about the main study measures (endpoints) may be shortened. Check the original registry record when a detail matters. Read our methodology